Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.05 - 0.1
Trade Value (12mth)
AU$1,794.00
1 week
7.94%
1 month
-12.82%
YTD
9.68%
1 year
36%
All time high
0.75
EPS 3 yr Growth
-54.20%
EBITDA Margin
%
Operating Cashflow
-$2m
Free Cash Flow Return
-102.10%
ROIC
-51.20%
Interest Coverage
N/A
Quick Ratio
6.40
Shares on Issue (Fully Dilluted)
202m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
04 July 25 |
Application for quotation of securities - FRE
×
Application for quotation of securities - FRE |
04 July 25 |
Cleansing Notice
×
Cleansing Notice |
04 July 25 |
Notification regarding unquoted securities - FRE
×
Notification regarding unquoted securities - FRE |
26 June 25 |
Firebrick Closes Placement at $0.2 milliion
×
Firebrick Closes Placement at $0.2 milliion |
26 June 25 |
Proposed issue of securities - FRE
×
Proposed issue of securities - FRE |
24 June 25 |
Trading Halt
×
Trading Halt |
23 June 25 |
Firebrick Pharma Investor Presentation 23 June 2025
×
Firebrick Pharma Investor Presentation 23 June 2025 |
10 June 25 |
Nasodine Phase 3 Common Cold Trial Published
×
Nasodine Phase 3 Common Cold Trial Published |
06 June 25 |
Withdrawal of Share Placement
×
Withdrawal of Share Placement |
05 June 25 |
Trading Halt
×
Trading Halt |
16 April 25 |
March 2025 Quarterly Activity Report & Appendix 4C
×
March 2025 Quarterly Activity Report & Appendix 4C |
28 March 25 |
Application for quotation of securities - FRE
×
Application for quotation of securities - FRE |
28 March 25 |
Cleansing Notice
×
Cleansing Notice |
21 March 25 |
Application for quotation of securities - FRE
×
Application for quotation of securities - FRE |
21 March 25 |
Cleansing Notice
×
Cleansing Notice |
06 March 25 |
Change in substantial holding - Peter Molloy
×
Change in substantial holding - Peter Molloy |
06 March 25 |
Change in substantial holding - Stephen Goodall
×
Change in substantial holding - Stephen Goodall |
06 March 25 |
Becoming a substantial holder - Firebrick Pharma
×
Becoming a substantial holder - Firebrick Pharma |
06 March 25 |
Becoming a substantial holder - Pharma Nutria NA Inc
×
Becoming a substantial holder - Pharma Nutria NA Inc |
05 March 25 |
Application for quotation of securities - FRE
×
Application for quotation of securities - FRE |
05 March 25 |
Cleansing Notice
×
Cleansing Notice |
04 March 25 |
FRE secures Strategic Investment from Philippines Partner
×
FRE secures Strategic Investment from Philippines Partner |
04 March 25 |
Proposed issue of securities - FRE
×
Proposed issue of securities - FRE |
28 February 25 |
Trading Halt
×
Trading Halt |
20 February 25 |
Appendix 4D & Half-Year Financial Report to 31 December 2024
×
Appendix 4D & Half-Year Financial Report to 31 December 2024 |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.